Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00427609 · ClinicalTrials.gov registry record · Phase 2
Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
A Phase 2 study, sponsored by University of Tennessee.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00427609: Clinical Trial Phase 2 study, sponsored by University of Tennessee.
NCT00427609 is a Phase 2 study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00427609, a Phase 2 study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy for Bicillin L-A, administered intramuscularly in a dose of 2.4 million units every three (3) weeks, for the treatment of chronic, plaque-type psoriasis unresponsive to topical medications or when other systemic therapies are contraindicated.
Interventions
- DRUG Bicillin L-A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Why NCT00427609 stopped before completion
NCT00427609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Bicillin L-A is the first listed.
NCT00427609 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00427609 about?
NCT00427609 is a clinical study titled "Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications". The purpose of this study is to determine the efficacy for Bicillin L-A, administered intramuscularly in a dose of 2.4 million units every three (3) weeks, for the treatment of chronic, plaque-type psoriasis unresponsive to topical medications or when other systemic therapies are contraindicated.
What is the current status of trial NCT00427609?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2007-01. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00427609?
The interventions under investigation include: Bicillin L-A (DRUG).
Who is sponsoring clinical trial NCT00427609?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00427609's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia